Long-term survival in giant cell arteritis including temporal arteritis and polymyalgia rheumatica. A follow-up study of 90 patients treated with corticosteroids

Acta Med Scand. 1986;220(4):361-4. doi: 10.1111/j.0954-6820.1986.tb02778.x.


Ninety patients with giant cell arteritis (GCA) were followed for 9-16 years after diagnosis. Corticosteroids were given to all but one patient. Forty-two patients died during the observation period (27 women and 15 men). The survival was compared with that in the general population and found not to be reduced among the GCA patients. In fact, we found a lower mortality than expected after five years from diagnosis (p less than 0.05). We did not see any increase in deaths due to vascular or malignant diseases in our patients.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adrenal Cortex Hormones / therapeutic use*
  • Aged
  • Female
  • Follow-Up Studies
  • Giant Cell Arteritis / complications
  • Giant Cell Arteritis / drug therapy
  • Giant Cell Arteritis / mortality*
  • Humans
  • Male
  • Middle Aged
  • Polymyalgia Rheumatica / complications
  • Polymyalgia Rheumatica / drug therapy
  • Polymyalgia Rheumatica / mortality*
  • Time Factors


  • Adrenal Cortex Hormones